Clinical Trials Logo
  1. Home
  2. Heparin
  3. NCT03113084

Study With Heparin Sodium in Subcutaneous Administration

Heparin Clinical Trial

Official title:
Phase I Study With Pharmacodynamic Determination of Unfractionated Heparin of Porcine Origin of the Company União Química of Subcutaneous Use in Healthy Participants

Clinical Trial Summary

The purpose of this phase I study is to know the pharmacodynamic profile in humans of the sodium heparin of porcine origin of the company União Química, building from the pharmacodynamic data generated its pharmacokinetic profile, due to the dosage limitation of heparin directly in biological samples. In addition, the toxicity of the product will be evaluated in healthy male participants.

Clinical Trial Description

This stage of product development follows the guidelines of the ANVISA (National Health Surveillance Agency) Heparin Development Guide.

Unfractionated sodium heparin is a drug known and widely used in the world for over half a century, thus, no unknown adverse events or any risk of administration are expected in humans, however, this is the first human Biological product developed by União Química. The proposed development of this biological drug follows the individual route, the control heparin used in the present study has the objective of evaluating the results found with the test product, without the obligation to demonstrate bioequivalence among the evaluated products. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03113084
Study type Interventional
Source União Química Farmacêutica Nacional S/A
Contact
Status Suspended
Phase Phase 1
Start date August 20, 2022
Completion date October 10, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT03470727 - The Effect of Citrate Dialysate on Clot Formation and Anemia in Hemodialysis Patients N/A
Recruiting NCT04496362 - Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study Phase 4
Recruiting NCT05875272 - Interchangeability of Arterial Coagulation and Venous Coagulation, in the Context of Cardiac Surgeries Under Cardiopulmonary Bypass, Using the DMDiv Hemochron Signature Elite
Completed NCT03143569 - Ventricular Assist Device Anti-Factor Xa (VAD ANTIX) Monitoring Study: a Prospective Randomized Feasibility Trial N/A
Recruiting NCT04861922 - Unfractioned Heparin for Treatment of Sepsis Caused by Abdominal Infection Phase 3
Completed NCT04767113 - Continuous Heparin Infusion to Prevent Catheter-related Thrombosis N/A
Completed NCT04355273 - Effects of Different Concentrations of Pressurized-heparin Flushing Fluid on Coagulation and Platelet Function Monitored by the Sonoclot Analyzer N/A
Completed NCT05439265 - EMR Tool Impact on HIT Documentation and Management
Recruiting NCT06109155 - The Effect of ACT and Tranexamic Acid on Bleeding in Cardiac Surgery Phase 4
Withdrawn NCT01454869 - The Effect of Heparin on Inhalation Injury Phase 3
Suspended NCT03125187 - Study With Heparin Sodium in Intravenous Administration Phase 1
Completed NCT05280106 - Citrate Dialysate in Online Hemodialfiltration N/A
Not yet recruiting NCT03113708 - The Effect of Heparinization Due to LBW Phase 4
Active, not recruiting NCT02785575 - Adjusted Calculation of Heparin and Protamin Dosing and Correlation With Postoperative Bleeding and Transfusions Phase 4